The Africa contraceptives market size was USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of XX% during 2023–2031. The growth of the market is attributed to the increasing incidences of sexually transmitted diseases, rising government initiatives, and growing rates of unwanted pregnancies. Rising awareness regarding modern contraception and usage of oral pills is estimated to drive the market.
Contraception is the method to prevent unwanted pregnancy with the use of devices and drugs. It is also known as fertility control and birth control. It is used in the contraception interfere in the normal process of sperm & ovum fertilization to prevent pregnancy. It prevents from pregnancy under the process of implantation, ovulation, and fertilization with the help of barriers, surgical techniques, drugs, and medical devices.
The devices are available in various shapes including triangle, coil, loop, and T-shaped that are of metal or plastic materials. There are various types of contraceptives available which acts as a different point under the process from implantation through ovulation to fertilization.
This method has its own risk and side effects. The contraceptive devices are majorly used in the hospitals and homecare. Covid-19 has impacted the contraceptives market as during lockdown going to physicians unnecessarily without emergency was limited.
Market Trends, Drivers, Restraints, and Opportunities
-
Rising development of female contraceptives drugs and devices is estimated to fuel the market growth in the coming years.
-
Growing awareness among population is major factors spurring the market expansion during the forecast period.
-
Side effects due to consumption of contraceptives acts as main challenge that can hinder the market growth.
-
Availability of alternative contraceptives methods is anticipated to impede the market expansion in the coming years.
-
R&D investment and technological advancement in contraceptives market is expected to offer significant opportunities for the market players.
Scope of Africa Contraceptives Market Report
The report on the Africa contraceptives market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Africa Contraceptives Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Products (Drugs [Tropical Contraceptives, Oral Contraceptives, and Contraceptive Injectable] and Devices [Diaphragms, Sponges, IUD, Condoms, Cervical Caps, Vaginal Rings, and Others]), Gender (Female and Male)
|
|
Regional Scope
|
Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Bayer AG; Pfizer Inc.; Allergan PLC; Merk & Co. Inc.; Teva Pharmaceuticals Industries Ltd.; SMB Corporation; Mayer Laboratories, Inc.; Okamoto Industries, Inc.; and Apothecus Pharmaceutical Corporation
|
Africa Contraceptives Market Segment Insights
Oral contraceptives segment is projected to account for a large market share
Based on products, the Africa contraceptives market is divided into drugs and devices. The drugs segment is further segregated into tropical contraceptives, oral contraceptives, and contraceptive injectable. The devices segment is further classified as diaphragms, sponges, IUD, condoms, cervical caps, vaginal rings, and others.
The oral contraceptives segment is expected to constitute a key share of the market during the forecast period owing to the easiest method of contraceptive, increasing number of unwanted pregnancies, and increasing occurrence of sexually transmitted diseases. The oral contraceptives taken in 2-3 days of unsafe sexual intercourse, so it helps to restrict implantation within uterus.
However, the condoms segment is anticipated to expand at a rapid pace during the forecast period due to long term effect and effectiveness. To fulfill the growing demand for the products and also to monitor the women’s health is expected to boost the market.
Male segment is projected to hold a key market share
On the basis of gender, the market is segmented into female and male. The male segment is expected to represent a key share of the market in the coming years due to rising number of commercialization of male birth control devices.
On the other hand, the female segment is anticipated to expand at a rapid pace during the forecast period owing to rising rates of unwanted pregnancies. The government is taking initiatives to decrease the rate of unwanted pregnancies is expected to boost the market.
Segments
The Africa contraceptives market has been segmented on the basis of
Products
- Drugs
- Tropical Contraceptives
- Oral Contraceptives
- Contraceptive Injectable
- Devices
- Diaphragms
- Sponges
- IUD
- Condoms
- Cervical Caps
- Vaginal Rings
- Others
Gender
Region
Key Players
- Bayer AG
- Pfizer Inc.
- Allergan PLC
- Merk & Co. Inc.
- Teva Pharmaceuticals Industries Ltd.
- SMB Corporation
- Mayer Laboratories, Inc.
- Okamoto Industries, Inc.
- Apothecus Pharmaceutical Corporation
Competitive Landscape
Key players competing in the Africa contraceptives market include Bayer AG; Pfizer Inc.; Allergan PLC; Merk & Co. Inc.; Teva Pharmaceuticals Industries Ltd.; SMB Corporation; Mayer Laboratories, Inc.; Okamoto Industries, Inc.; and Apothecus Pharmaceutical Corporation.
Some of these players are engaged in several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.
Request For Customization
Enquiry Before Buying
Speak With Analyst
